Impact of Hepatitis Virus on the Feasibility and Efficacy of Anticancer Agents in Patients With Hepatocellular Carcinoma in Phase I Clinical Trials

Chronic viral hepatitis is a risk factor for liver fibrosis and hepatocellular carcinoma (HCC). Patients with advanced HCC have limited effective therapeutic options and are considered potential candidates for early phase clinical trials of anti-cancer agents. The impact of chronic viral hepatitis o...

Descripción completa

Detalles Bibliográficos
Autores principales: Koyama, Takafumi, Kondo, Shunsuke, Shimizu, Toshio, Fujiwara, Yutaka, Morizane, Chigusa, Sakamoto, Yasunari, Okusaka, Takuji, Yamamoto, Noboru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482236/
https://www.ncbi.nlm.nih.gov/pubmed/31058094
http://dx.doi.org/10.3389/fonc.2019.00301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482236/
https://www.ncbi.nlm.nih.gov/pubmed/31058094
http://dx.doi.org/10.3389/fonc.2019.00301

Ejemplares similares